In gliomas, CXCL10 expression is mainly regulated by the type-I IFN pathway, particularly influenced by poly(I)-induced IFN autocrine and paracrine signaling through IFNAR1 activation [48]. This evidence concerns the gene CXCL10 and central nervous system cancer.